Screener
ALX Oncology Holdings Inc. ALXO Q3 2025 earnings
Reported November 7, 2025 · Before market open
EPS-$0.41Miss by $0.04
EPS estimate-$0.37
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.15
Versus estimates
Diluted EPS
FAQ
- When did ALX Oncology Holdings Inc. report Q3 2025 earnings?
- ALX Oncology Holdings Inc. (ALXO) reported Q3 2025 earnings on November 7, 2025 before market open.
- What were ALX Oncology Holdings Inc.'s Q3 2025 revenue and EPS?
- ALX Oncology Holdings Inc. reported eps of $-0.41 for Q3 2025.
- Did ALX Oncology Holdings Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.37 by $0.04.
- How did ALX Oncology Holdings Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 29.3% from $-0.58.
- Where can I find ALX Oncology Holdings Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-271112) and the 10-Q periodic report (0001193125-25-272281) directly on SEC EDGAR. The filing index links above go to sec.gov.
